pUC19_CoV-2_ frD2_ΔE67 3* F-P2A-N DS Cav1 ΔCT
(Plasmid
#253167)
-
PurposeFor recombinant virus rescue; encodes fragment D2 of SARS-CoV-2 (nt25422-29867), with deletion of orf3a, envelope, orf6, orf7a;stop codon at AA213 in orf3a; preF stabilized RSV F-P2A-N
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 253167 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepUC19
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameCoV-2 frD2 with RSV preF
-
SpeciesSARS-CoV-2, Respiratory syncytial virus (RSV)
Cloning Information
- Cloning method Gibson Cloning
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
detailed explanation of CLEVER reverse genetics methodology in DOI: 10.7554/eLife.89035
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pUC19_CoV-2_ frD2_ΔE67 3* F-P2A-N DS Cav1 ΔCT was a gift from Thomas Klimkait (Addgene plasmid # 253167 ; http://n2t.net/addgene:253167 ; RRID:Addgene_253167) -
For your References section:
Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform. Kipfer ET, Hauser D, Lett MJ, Otte F, Urda L, Zhang Y, Lang CMR, Chami M, Mittelholzer C, Klimkait T. Elife. 2023 Nov 21;12:RP89035. doi: 10.7554/eLife.89035. 10.7554/eLife.89035 PubMed 37988285